Shuwen Biotech Approved for European Use of EGFR Test

Published on: Sep 18, 2017
Author: Amy Liu

Shuwen Biotech of Hangzhou received CE-IVD marking for its EGFR real time PCR detection kit, allowing European use of the test. The EGFR kit, which analyzes 29 mutations in exons 18, 19, 20 and 21, is one of five kits Shuwen offers for analysis of mutations associated with lung cancer. Shuwen also offers kits for lung and colorectal cancer mutations. The company, led by US and European diagnostic veterans, develops its own products and also in-licenses IVD products from outside China.

Source: China Biotoday

Biotechnology China News Pharmaceutical